<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: New Animal Drugs; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: New Animal Drugs; Chorionic Gonadotropin; Naloxone; Oxymorphone; Oxytocin</h1>
    <p class="timestamp">Published: 2012-09-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of four new animal drug applications (NADAs) at the sponsor's request because the products are no longer manufactured or marketed.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2012-22196</p>
    <p><strong>Publication Date:</strong> 2012-09-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2012/09/10/2012-22196/new-animal-drugs-chorionic-gonadotropin-naloxone-oxymorphone-oxytocin">https://www.federalregister.gov/documents/2012/09/10/2012-22196/new-animal-drugs-chorionic-gonadotropin-naloxone-oxymorphone-oxytocin</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2012-22196</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
